These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38233284)

  • 1. Positron Emission Tomography/Computed Tomography Transformation of Oncology: Melanoma and Skin Malignancies.
    Lee ST; Kovaleva N; Senko C; Kee D; Scott AM
    PET Clin; 2024 Apr; 19(2):231-248. PubMed ID: 38233284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical applications of fluorodeoxyglucose--positron emission tomography in the management of malignant melanoma.
    Kumar R; Alavi A
    Curr Opin Oncol; 2005 Mar; 17(2):154-9. PubMed ID: 15725921
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Jaeger ZJ; Williams GA; Chen L; Mhlanga JC; Cornelius LA; Fields RC
    J Surg Oncol; 2022 Mar; 125(3):525-534. PubMed ID: 34741547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational use of
    Bisschop C; de Heer EC; Brouwers AH; Hospers GAP; Jalving M
    Crit Rev Oncol Hematol; 2020 Sep; 153():103044. PubMed ID: 32673997
    [No Abstract]   [Full Text] [Related]  

  • 5. Review on radiomic analysis in
    Amrane K; Meur CL; Thuillier P; Berthou C; Uguen A; Deandreis D; Bourhis D; Bourbonne V; Abgral R
    Cancer Imaging; 2024 Jul; 24(1):87. PubMed ID: 38970050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Earlier Recurrence Detection Using Routine FDG PET-CT Scans in Surveillance of Stage IIB to IIID Melanoma: A National Cohort Study of 1480 Patients.
    Helvind NM; Weitemeyer MB; Chakera AH; Hendel HW; Ellebæk E; Svane IM; Kjærskov MW; Bojesen S; Skyum H; Petersen SK; Bastholt L; Johansen C; Bidstrup PE; Hölmich LR
    Ann Surg Oncol; 2023 Apr; 30(4):2377-2388. PubMed ID: 36752970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value of whole body
    Bower N; Morris A; O'Connor J; Sponagle M; Bahr R; Gilbert R; Mohamed A; Bower J
    J Med Imaging Radiat Sci; 2024 Jun; 55(2):212-220. PubMed ID: 38403520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restaging [
    Mahajan S; Barker CA; Mauguen A; Singh B; Pandit-Taskar N
    J Am Acad Dermatol; 2020 Apr; 82(4):878-886. PubMed ID: 31562942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical use of positron emission tomography in the management of cutaneous melanoma.
    Friedman KP; Wahl RL
    Semin Nucl Med; 2004 Oct; 34(4):242-53. PubMed ID: 15493002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma.
    Lee JW; Nam SB; Kim SJ
    Oncology; 2019; 97(5):286-293. PubMed ID: 31437839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
    Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
    Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-Fluorodeoxyglucose-PET-Computerized Tomography and non-Fluorodeoxyglucose PET-Computerized Tomography in Hepatobiliary and Pancreatic Malignancies.
    Gnanasegaran G; Agrawal K; Wan S
    PET Clin; 2022 Jul; 17(3):369-388. PubMed ID: 35717098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of PET-CT in the staging and management of advanced and recurrent malignant melanoma.
    Twycross SH; Burger H; Holness J
    S Afr J Surg; 2019 Sep; 57(3):44-49. PubMed ID: 31392864
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Hicks RJ; Iravani A; Sandhu S
    PET Clin; 2020 Jan; 15(1):11-22. PubMed ID: 31735298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of positron emission tomography scan in stage III cutaneous melanoma: a systematic review and meta-analysis.
    Rodriguez Rivera AM; Alabbas H; Ramjaun A; Meguerditchian AN
    Surg Oncol; 2014 Mar; 23(1):11-6. PubMed ID: 24556310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorodeoxyglucose-PET in the management of malignant melanoma.
    Kumar R; Mavi A; Bural G; Alavi A
    Radiol Clin North Am; 2005 Jan; 43(1):23-33. PubMed ID: 15693645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Prognostic Value of
    Albano D; Familiari D; Fornito MC; Scalisi S; Laudicella R; Galia M; Grassedonio E; Ruggeri A; Ganduscio G; Messina M; Spada M; Midiri M; Alongi P
    Curr Radiopharm; 2020; 13(1):42-47. PubMed ID: 31595860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of FDG PET-CT in cutaneous melanoma].
    Nicol I; Chuto G; Gaudy-Marqueste C; Brenot-Rossi I; Grob JJ; Richard MA
    Bull Cancer; 2008 Nov; 95(11):1089-101. PubMed ID: 19036682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of preoperative (18)F-FDG PET-CT in lymphatic metastasis diagnosis of cutaneous malignant melanoma on extremities and trunk].
    Zhang XX; Fang Y; Xu LB; Xu SF; Zhao ZG; Sun C; Ma PQ; Liu T; Yu SJ; Zhang WJ
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):372-378. PubMed ID: 29860765
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical Value of PET/CT in Staging Melanoma and Potential New Radiotracers.
    Annunziata S; Laudicella R; Caobelli F; Pizzuto DA; Aimn Working Group Y
    Curr Radiopharm; 2020; 13(1):6-13. PubMed ID: 31749438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.